From influenza to SARS-CoV-2: etiological evaluation of acute benign childhood myositisOriginal Article Published on 2021-08-242023-06-14 Journal: Acta neurologica Belgica [Category] MERS, [키워드] Acute benign myositis childhood creatine kinase [DOI] 10.1007/s13760-021-01785-0 PMC 바로가기 [Article Type] Original Article
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis코로나바이러스 2019(COVID-19)의 중증 질환 및 사망률과 관련된 심장 바이오마커, 심장 손상 및 동반 질환: 체계적인 검토 및 메타 분석Review Published on 2021-08-182022-09-10 Journal: Immunity, Inflammation and Disease [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Acute cardiac injury acute myocardial injury Biomarker Biomarkers cardiac Cardiac biomarkers cardiac injury cardiovascular disease certainty Clinical research clinical trial clinical trials CNKI Cochrane Library Comorbidities Comorbidity coronavirus disease correlation COVID‐19 COVID‐19 patients COVID‐19 creatine creatine kinase Critical event Evidence except for groups help hypertension IMPROVE Injury Laboratory laboratory parameter Laboratory parameters Lactate lactate dehydrogenase LDH mean difference measure medRxiv meta‐analysis Mortality MOST myocardial injury Myoglobin no difference NT‐proBNP Odds ratio outcome outcome measures Patient patients peptide pool Relative risk Research Result risk SARS‐CoV‐2 sensitivity Serum level severe group severity SinoMed SMD systematic review systemically TnI total sample size Treatment troponin I VIP was performed was related Web of Science [DOI] 10.1002/iid3.471 PMC 바로가기 [Article Type] Review
COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort StudySARS-CoV-2 B.1.1.7 변종 중국의 첫 번째 지역 발병으로 인한 COVID-19 사례가 더 심각한 임상 특징을 나타낼 수 있음: 전향적, 비교 코호트 연구Research Article Published on 2021-08-042022-09-10 Journal: Microbiology Spectrum [Category] MERS, SARS, 변종, 치료기술, 치료제, [키워드] acute response age amyloid A B.1.1.7 B.1.1.7 variant Beijing C-reactive protein caused CD4 China clinical Clinical characteristics clinical feature Clinical features Clinical tests Comparative conducted contagious COVID-19 COVID-19 case COVID-19 cases COVID-19 outbreak COVID-19 patient COVID-19 patients creatine creatine kinase CRP d -dimer database diagnoses dimer District elevated Epidemics Features Fever GGO ground-glass opacity Infection Inflammatory response knowledge lead lung Lymphocytes median N gene occurred outbreak p value p values pathogenicity Pneumonia present proportion Prospective quantitative PCR reported reverse transcriptase risk factor RT-qPCR SAA SARS-CoV-2 SARS-CoV-2 B.1.1.7 SARS-CoV-2 strain serum amyloid severe pneumonia significantly higher significantly lower T lymphocyte T lymphocytes The B.1.1.7 the SARS-CoV-2 threshold transcriptase Transmission triggered United Kingdom variant Viral Viral load viral loads whole-genome analysis [DOI] 10.1128/Spectrum.00273-21 PMC 바로가기 [Article Type] Research Article
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysisCOVID-19 환자의 진행 및 사망률에 대한 일반적인 위험 요소: 메타 분석Meta-Analysis Published on 2021-08-012022-09-11 Journal: Archives of Virology [Category] MERS, SARS, 바이오마커, [키워드] affected Alanine alanine aminotransferase ALT Bacteria bilateral pneumonia Bilirubin C-reactive protein caused Cerebrovascular disease CHD Chronic kidney disease CKD clinical manifestations Cochrane Library Coinfection Comorbidities Coronary heart disease coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity creatine creatine kinase CRP CVD database death in COVID-19 Deceased defined fungi global public health global public health emergency Health Organization heart disease hemoptysis identify increased risk investigated Kidney disease Laboratory laboratory examinations lymphocyte Lymphocyte count malignancy Meta-analysis Mortality N-terminal neutrophil neutrophil count non-severe group NT-proBNP participant Patient patients patients worldwide peptide Platelet Platelet count Pneumonia progression proportion risk factor Risk factors severe group significantly higher significantly more sputum production survival group total bilirubin was performed WHO World Health Organization [DOI] 10.1007/s00705-021-05012-2 PMC 바로가기 [Article Type] Meta-Analysis
Muscle Damage Biomarkers in Congestion Weeks in English Premier League Soccer Players: A Prospective Study for Two Consecutive Seasons잉글랜드 프리미어 리그 축구 선수의 혼잡 주간 근육 손상 바이오마커: 연속 2시즌에 대한 전향적 연구Article Published on 2021-07-282022-09-10 Journal: International Journal of Environmental Research an [Category] SARS, 바이오마커, [키워드] age Biomarker body mass club collected conducted congestion COVID-19 pandemic creatine creatine kinase damage Department Dexa English enrolled exposure time fat fatigue GPS Height high speed running lean mass lockdown Medical Department Midfielder muscle muscle damage outcome performed position Prospective prospective cohort study Questionnaires room season Significance significantly increased soccer substitutions Week weight [DOI] 10.3390/ijerph18157960 PMC 바로가기 [Article Type] Article
Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy2019년 코로나바이러스 감염증 입원환자 교정 QT 간격: 약물치료를 중심으로Observational Study Published on 2021-07-162022-09-11 Journal: Medicine [Category] SARS, 임상, 치료제, [키워드] 95% CI 95% confidence interval administration Antiviral agents Arbidol Biomarker Campus cardiac injury Chloroquine chloroquine/hydroxychloroquine confirmed COVID-19 case coronavirus disease Coronavirus disease 2019 COVID-19 severity creatine creatine kinase Creatine kinase-MB drug Drug administration Effect exhibited focus fraction hospitalized patient Hydroxychloroquine increased the risk Injury interferon less Lopinavir Lopinavir/ritonavir Mortality Odds ratio Patient patients treated peptide positively correlated Prognosis QT interval QTc QTc interval QTC prolongation receiving risk Ritonavir severity significant effect study cohort therapy treated Treatment troponin I Union Hospital West with COVID-19 Wuhan [DOI] 10.1097/MD.0000000000026538 PMC 바로가기 [Article Type] Observational Study
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trialSARS Cov-2 감염으로 입원한 환자에서 아스피린, 아토르바스타틴, 니코란딜을 사용한 삼중 요법의 효능과 안전성을 평가하기 위한 무작위 공개 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-07-152022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 ACHE Acute coronary syndrome Acute kidney injury acute renal failure adequate hydration adjuvant therapy Admission allergy ALT/AST Altered mental status Anti-inflammatory anticoagulation antipyretics Antithrombotic approved ARDS Aspirin AST/ALT atorvastatin bleeding Blinding block randomization Breastfeeding brown urine change characterized clinical clinical feature Clinical features Coagulopathy college Combination comorbid condition comorbid conditions comparator conducted control group coronary syndrome Corticosteroid Corticosteroids cough COVID-19 CPK creatine creatine kinase creatinine CRP current therapy Dexamethasone dissemination dose drug dysfunction Dyspnoea dysregulation effective Efficacy and safety element Endothelial dysfunction enrolled ethical committee evaluate excluded ferritin Fever followed by greater heparin hepatotoxicity Hospital admission hospital discharge Hospital mortality Hospital stay hospitalised patient Hospitalised patients hyperbilirubinemia hypoxia ICMR IEC immune dysregulation immunomodulatory impaired consciousness in-hospital mortality India Inflammation Inflammatory marker inflammatory markers Intervention intervention group intolerance intravenous Intravenous remdesivir invasive limit liver low molecular weight low molecular weight heparin management marker mechanical ventilation medication medications moderate muscle ache myalgia Myoglobin Myopathy myositis national guidelines Nicorandil Non-invasive number objective once daily Open-label open-label trial outcome oxygen Oxygen requirement oxygen support participant pathophysiologic pathophysiology Patient Platelet Platelet count Pneumonia positive Pregnancy Primary outcome progression protocol raised Rajendra Prasad Randomised control trial randomization randomize Randomized Randomized controlled trial randomly divided receive recruitment reducing mortality Registered registry Remdesivir renal failure reported respiratory rate rhabdomyolysis room air RT-PCR safety endpoint safety endpoints Sample size SARS-CoV-2 infected patient SARS-COV-2 infection Schematic screened Secondary outcomes Sepsis serum serum markers severe disease Shock significant interaction SpO2 Standard Standard of care starting dose statin statins Study design Study protocol substrates supplementary material Symptom Symptomatic treatment Tablet therapeutic therapeutic agent therapy thrombocytopenia Treatment Trial Trial registration two-arm parallel ULN Urine weakness website [DOI] 10.1186/s13063-021-05361-y PMC 바로가기 [Article Type] Letter
SARS-CoV-2 Infection and Emery-Dreifuss Syndrome in a Young Patient with a Family History of Dilated Cardiomyopathy확장성 심근병증의 가족력이 있는 젊은 환자의 SARS-CoV-2 감염 및 Emery-Dreifuss 증후군Case Reports Published on 2021-07-142022-09-10 Journal: Genes [Category] SARS, 변종, 치료기술, [키워드] Affect anamnesis antihypertensive medication Arm ARMS Arterial hypertension Cardiac pathology cardiac troponin Cardiac troponin I cardiological Cardiology Cardiology Department Cardiomyopathy clinical manifestations creatine creatine kinase Department described diagnosed Diagnosis dilated cardiomyopathy discharge disorder dynamic ECGs electrocardiogram Electrocardiograms electrocardiographic Emery–Dreifuss syndrome extension family genetic disease genetic tests heart Heart transplantation heel strike heterozygous high-sensitive cardiac troponin I history Hospitalization Hospitalized hypertension ICD Implantable cardioverter-defibrillator Infectious disease initiated limitation LMNA medical history Mild MRI muscular muscular dystrophy Musculoskeletal musculoskeletal system Mutation myocarditis N-terminal NEUROLOGY NT-proBNP Numerous obesity past Patient peptide performed placement SARS-CoV-2 SARS-CoV-2 virus SARS-CoV-2 virus infection stage 2 suspicion Tachycardia the patient transferred Treatment troponin I variant ventricular ventricular extrasystoles ventricular tachycardia Viral viral myocarditis virus infection walking was performed [DOI] 10.3390/genes12071070 PMC 바로가기 [Article Type] Case Reports
Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa리비아에서 입원한 COVID-19 환자의 역학 및 임상 프리젠테이션: 아프리카의 초기 보고서Article Published on 2021-07-012022-09-11 Journal: Travel medicine and infectious disease [Category] SARS, 변종, [키워드] Acute cardiac injury Acute kidney injury acute respiratory syndrome Africa age Alanine analyzed arrhythmia aspartate Aspartate aminotransferase Bilirubin blood cell cardiac injury Chronic kidney disease circulatory shock clinical presentation Clinical presentations Comorbidities Comorbidity complications coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 creatine creatine kinase Creatine kinase-MB creatinine creatinine kinase D-dimer demographics descending determine diabetes Diabetes Mellitus diagnosed died distress epidemiological Epidemiology hospitalized COVID-19 patient hospitalized patient hospitalized patients hypersensitive hypertension Hypotension initial Injury intensive care intensive care unit International interquartile range Kidney disease Kidney injury Laboratory laboratory characteristics Libya Local Lung disease Lung diseases lymphocyte median men monocyte neutrophil Non-survivors Novel coronavirus novel coronavirus disease occurred outcome pandemic Patient patients patients hospitalized Platelet platelet counts predominant respiratory distress Respiratory distress syndrome retrospective Severe acute respiratory syndrome Shock study period syndrome the patient total bilirubin variants White blood cell with COVID-19 women [DOI] 10.1016/j.tmaid.2021.102064 PMC 바로가기 [Article Type] Article
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysisCOVID-19 입원의 바이오마커 및 결과: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-06-012022-08-31 Journal: BMJ evidence-based medicine [Category] MERS, SARS, 바이오마커, [키워드] 2019-nCoV 95% CI Admission Alanine alanine aminotransferase ALT aspartate Aspartate aminotransferase association AST Biomarker Biomarkers C reactive protein clinical decision Composite Consensus coronavirus COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients COVID-19 severity creatine creatine kinase creatinine Critical Critical care CRP D-dimer Decision making Diseases elevated English evaluate evidence-based practice forest plot forest plots global health healthcare heterogeneity high-risk patient High-risk patients higher risk hospitalised patient Hospitalised patients IMPROVE In-hospital include independent Infectious disease infectious disease medicine Infectious diseases intensive care intensive care unit admission Invasive mechanical ventilation Laboratory laboratory findings Lactate lactate dehydrogenase LDH lymphocyte lymphopenia management medical subject heading Medical Subject Headings meta-analyses Meta-analysis MOOSE Mortality nCoV observational studies observational study outcome outcomes oxygen oxygen saturation pandemic PCT Platelets procalcitonin Prognosis Publication bia publication bias Random-effects models resource resources SARS-CoV-2 selected sensitivity analysis severe disease Severity of disease systematic review thrombocytopenia Web of Science were assessed [DOI] 10.1136/bmjebm-2020-111536 PMC 바로가기 [Article Type] Meta-Analysis